Tirzepatide vs Semaglutide vs Retatrutide: A Receptor-Level Comparison

The incretin class has expanded rapidly. Where semaglutide is a pure GLP-1 receptor agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide adds glucagon receptor activity for a triple-agonist profile.

At the molecular level, all three share a lipidated C-terminus that extends half-life via albumin binding. Tirzepatide and retatrutide both use a C20 diacid chain; semaglutide uses a C18 diacid. This is a key reason the three peptides resist enzymatic degradation differently in serum-stability assays.

In receptor-binding studies, EC50 values diverge meaningfully across cell lines. Researchers comparing these analogs should standardize on a single reporter system (cAMP accumulation assays are most common) and verify peptide mass by LC-MS before each experiment.

Storage and handling differ slightly. All three are typically supplied as lyophilized powder and should be stored at -20°C long-term. Once reconstituted with bacteriostatic water, working stocks are most stable refrigerated and used within two to four weeks.

For research use only. Not intended for human or veterinary use.